Literature DB >> 31815806

Cash-Based Stem-Cell Clinics: The Modern Day Snake Oil Salesman? A Report of Two Cases of Patients Harmed by Intra-articular Stem Cell Injections.

John Taliaferro1, Shane A Shapiro1, Daniel P Montero1, Glenn G Shi1, Benjamin K Wilke1.   

Abstract

CASE: The use of biologics is rapidly expanding. Over the past decade, there has been a significant increase in the number of cash-based "stem cell"/regenerative medicine clinics in the United States. These clinics provide cash-based services touting stem cell injections to cure a myriad of conditions. Largely, these clinics are unregulated and using injections in a non-Food and Drug Administration-approved manner. We report on 2 patients who presented with symptoms suggestive of septic arthritis following stem cell injections by cash-based local stem cell clinics. Case 1 involved a patient who developed septic arthritis following an injection of umbilical cord blood-derived cellular products (Genentech) and required an antibiotic spacer followed by a total hip arthroplasty. Case 2 involved a patient who developed a likely immune-mediated reaction following an injection of morselized human placental allograft tissue by a local chiropractic office at a cost of approximately $8,000.
CONCLUSIONS: We present these cases to bring increased awareness to the issue and call for increased regulation of this practice.

Entities:  

Year:  2019        PMID: 31815806     DOI: 10.2106/JBJS.CC.19.00363

Source DB:  PubMed          Journal:  JBJS Case Connect        ISSN: 2160-3251


  2 in total

1.  Evaluation of Patient Preference and Perception Regarding the Clinical Use of Autologous Versus Allogeneic Cell Therapy in Orthopedic Surgery.

Authors:  Claire D Eliasberg; Daniel A Nemirov; Samuel J E Green; Stephen G Melancon; Scott A Rodeo
Journal:  HSS J       Date:  2021-05-22

2.  The Direct to Consumer Stem Cell Market and the Role of Primary Care Providers in Correcting Misinformation.

Authors:  Jennifer R Arthurs; Charlene M Martin Lillie; Zubin Master; Shane A Shapiro
Journal:  J Prim Care Community Health       Date:  2022 Jan-Dec
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.